Food BioSciences Department, Teagasc Food Research Centre, Ashtown, D15 DY05 Dublin, Ireland.
Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Avenue Agustín Escardino 7, Valencia, 46980 Paterna, Spain.
Mar Drugs. 2024 Jun 27;22(7):297. doi: 10.3390/md22070297.
This study generated bioactive hydrolysates using the enzyme Alcalase and autolysis from mesopelagic fish, including and . Generated hydrolysates were investigated for their bioactivities using in vitro bioassays, and bioactive peptides were identified using mass spectrometry in active hydrolysates with cyclooxygenase, dipeptidyl peptidase IV and antioxidant activities. In silico analysis was employed to rank identified peptide sequences in terms of overall bioactivity using programmes including Peptide Ranker, PrepAIP, Umami-MRNN and AntiDMPpred. Seven peptides predicted to have anti-inflammatory, anti-type 2 diabetes or Umami potential using in silico strategies were chemically synthesised, and their anti-inflammatory activities were confirmed using in vitro bioassays with COX-1 and COX-2 enzymes. The peptide QCPLHRPWAL inhibited COX-1 and COX-2 by 82.90% (+/-0.54) and 53.84%, respectively, and had a selectivity index greater than 10. This peptide warrants further research as a novel anti-inflammatory/pain relief peptide. Other peptides with DPP-IV inhibitory and Umami flavours were identified. These offer potential for use as functional foods or topical agents to prevent pain and inflammation.
本研究使用酶 Alcalase 和来自中层鱼类的自溶作用生成生物活性水解产物,包括 和 。使用体外生物测定法研究了生成的水解产物的生物活性,并使用具有环加氧酶、二肽基肽酶 IV 和抗氧化活性的活性水解产物通过质谱鉴定生物活性肽。使用包括 Peptide Ranker、PrepAIP、Umami-MRNN 和 AntiDMPpred 在内的程序,通过计算机分析对鉴定的肽序列进行了整体生物活性的排序。使用计算机策略预测具有抗炎、抗 2 型糖尿病或鲜味潜力的七种肽被化学合成,并使用 COX-1 和 COX-2 酶的体外生物测定法证实了它们的抗炎活性。肽 QCPLHRPWAL 对 COX-1 和 COX-2 的抑制率分别为 82.90%(+/-0.54)和 53.84%,且选择性指数大于 10。该肽值得进一步研究,作为一种新型抗炎/止痛肽。还鉴定了具有 DPP-IV 抑制和鲜味的其他肽。这些肽有可能用作功能性食品或局部制剂,以预防疼痛和炎症。